Women's Health
Basic InformationLatest News
Lots of Sugary Drinks Doubles Younger Women's Colon Cancer Risk: StudyHeart Risk Factors Show Up Earlier in U.S. Black WomenBetter Access to Birth Control Boosts School Graduation RatesA Vitamin Could Be Key to Women's Pain After Knee ReplacementFreezing Tumors Could Be New Treatment for Low-Risk Breast CancersGiving Birth During the Pandemic? Facts You Need to KnowDo Your Genes Set You Up for Hot Flashes?Common Complication of Pregnancy Tied to Higher Stroke Risk LaterMigraine Before Menopause Could Be Linked to High Blood Pressure LaterA Woman's Weight Might Affect Her Odds for MiscarriageBreast Cancer Over 70: How Much Treatment Is Enough?Nurses Are Dying From Suicide at Higher RatesUrinary Incontinence Surgery Won't Raise a Woman's Cancer RiskOvarian Cancer Diagnosis Can Take Big Toll on Women's Mental HealthObesity May Help Trigger Heavier Periods: StudyWomen More Prone to Concussion's Long-Term Harms: StudyMammogram Rates Have Rebounded Since Pandemic Began, But Concerns RemainHeart Disease Gaining on Cancer as Leading Cause of Death in Young WomenWhat Is Endometriosis, and How Is It Treated?OCD May Be More Common in New Moms Than ThoughtAn IUD Could Ward Off Endometrial Cancer in Women at RiskEven a Little Coffee in Pregnancy Could Impact Newborn's Weight: StudyDrug Boosts Survival for Women With Advanced Ovarian CancerPostpartum Bleeding Doesn't Have to Mean Hysterectomy, Experts SayPandemic Has Pregnant Women 'Really Stressed,' Survey ShowsMany U.S. Mammography Centers Aren't Following Expert Guidelines: ReportBlack Women More Prone to Postmenopausal Weight Gain Than White WomenMost Women Can Give Birth Naturally Even When Water Breaks Early: StudyCommon Household Chemicals Tied to Preemie BirthsLockdowns Tougher on Women, and Housework Is Big Reason WhyTHC From Pot Lingers in Breast Milk for Weeks: StudyBreastfeeding Moms Get Mixed Messages When Baby Has an AllergyHigh Blood Pressure in Pregnancy Is Linked to Shorter Life Spans for WomenDevice Used for Thousands of Years Eases Major Cause of Female Urinary ProblemsLots of Belly Fat at Menopause Could Boost Heart RisksA Vaccine Against UTIs? New Mouse Study Brings Shot CloserWomen With Type 1 Diabetes May Have Fewer Childbearing Years: StudyMany Women Getting Wrong Antibiotics to Treat a UTI: StudyHigh Blood Pressure in Pregnancy Could Affect Women's Hearts Long TermSwitch to Plant-Based Diet Could Protect Older Women's Brains3D Mammograms Best at Spotting Tumors, But Many Black Women Missing OutNew Drug Combo Could Be Advance Against Uterine FibroidsUrinary Incontinence a Common Issue for Older Women, But Treatments Can HelpMore Young U.S. Women Are Dying From Heart DiseaseIs Any Amount of Coffee Safe for Baby During Pregnancy?COVID Vaccine Reaction Can Mimic Breast Cancer Symptoms, But Doctors Say 'Don't Panic'Prescription Opioids, Antibiotics in Pregnancy Won't Raise Birth Defect Risk: StudiesAHA News: Why Black Women Are Less Likely to Survive Pregnancy, and What's Being Done About ItAfter Long Decline, Breast Cancers in Young U.S. Women Are On the RiseDiabetes While Pregnant Ups Odds for Heart Disease Later
Questions and AnswersVideosLinksBook ReviewsSelf-Help Groups
Related Topics

Medical Disorders
Wellness and Personal Development
Mental Disorders

Can Women With Early Breast Cancer Skip Post-Op Radiation?

HealthDay News
by By Cara Roberts Murez
HealthDay Reporter
Updated: Aug 20th 2020

new article illustration

THURSDAY, Aug. 20, 2020 (HealthDay News) -- Instead of weeks of radiation following a lumpectomy, a new study shows that many women with early breast cancer do just as well with only a single dose of targeted radiation that is given during their surgery.

"Breast cancer outcomes, in terms of cancer coming back, breast cancer survival, dying from breast cancer, being mastectomy-free, being free of disease elsewhere in the body, all are exactly the same as the usual six weeks of radiation," Dr. Jayant Vaidya, a professor of surgery and oncology at University College London (UCL), said of the single-dose therapy.

"But the most important point was there was a reduction in deaths from causes other than breast cancer," Vaidya said.

The trial, which involved nearly 2,300 women receiving treatment between 2000 and 2012, found the single-dose method to be an effective alternative after following up with patients for a median length of more than eight years.

Three of the study authors -- Vaidya, Dr. Michael Baum and Dr. Jeffrey Tobias, all from UCL in the United Kingdom -- first embarked on the research about two decades ago. They theorized that radiotherapy focused on the area around the tumor right after the tumor was removed would be enough, Vaidya said, and they made the treatment device in collaboration with industry. In 1998, they treated the first patient using this method.

Gradually, other medical centers joined the trial, learning the technique, treating patients within the parameters of the trial and sending along follow-up information. Eligibility criteria were that women be 45 and older and have invasive ductal carcinoma up to 3.5 centimeters in size. Providers from around the world participated in the study, with patients at 32 medical centers in 10 countries, including the United States.

Prior to the latest results, it was already known that when breast cancer is treated by lumpectomy instead of mastectomy, whole breast radiation in multiple doses reduces the risk of recurrence of cancer in that area, the study authors said.

Also known -- because of earlier results from the latest study -- was the fact that restricting radiotherapy to just the area around the tumor during the surgery avoided delays in radiation and had patient advantages that included less traveling for treatment, improved quality of life and fewer side effects.

The new information added by this part of the study shows that the single-dose method has "similar long-term local control and cancer survival outcomes to whole breast radiotherapy," according to the report.

Local recurrence of cancer for patients who received the targeted, single dose of radiation was 2.1% at five years, compared to 0.95% of those who received external beam radiotherapy, a number not considered to be clinically significant. Patients who received the single dose also had fewer other cancers, and fewer lung or cardiovascular health problems, Vaidya said. It is unclear why this happened.

"Radiation is known to have side effects if there's scattered radiation when we do whole breast radiation. This radiation is focused. That could be one reason," Vaidya said.

"It could also be that radiation given during surgery at the right time has other beneficial effects," he added. "Whatever the reason, it is a randomized trial and we found a difference and that difference is real. It is not only statistically significant, it is a substantial difference."

Breast cancer affects millions of women worldwide each year. In 2018 alone, 2 million patients were diagnosed with breast cancer, and 626,000 people died of the disease. Most patients can choose to have breast-conserving surgery and radiation, rather than mastectomy.

In 80% of these cases, this single dose of radiation is all they need, Vaidya said. For the other 20%, postoperative results indicate those patients need whole breast radiation.

Benefits to this treatment also include lower cost, Vaidya said. The treatment is already available in about 260 centers around the world, including about 80 centers in the United States. About 45,000 women have had the single-dose treatment, he noted.

The study findings were published online Aug. 19 in the BMJ.

Dr. William Cance, chief medical and scientific officer for the American Cancer Society, said both the large size of the study and the long length of follow-up time were positive factors.

Patients have many choices today for radiation, Cance noted. Choosing to have radiation during surgery may be a quality-of-life issue, and possibly more so in the COVID-19 era, because patients would not need to make repeated trips back to their health care facility for continued treatment.

One limiting factor could be if a patient's medical institution does not have the capability and experience to offer this type of radiation, Cance said.

"I think having the facility that does it will be one of the limiting factors, but I believe it's a promising therapy where less treatment is at least no worse and, as this study shows, it may have some advantages long term," he added.

More information

The U.S. National Cancer Institute has more on breast cancer treatment.


Amazon Smile


Children and Adult services are available now with no wait time.  

Please contact HBH at 860-548-0101, option 2.


powered by centersite dot net